Complete stable remission and autoantibody specificity in myasthenia gravis
Citation Manager Formats
Make Comment
See Comments
AAN Members
我们已经改变了改善acc登录过程ess between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be foundhere
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to ourSubmission Siteto add or update your Disclosure information.
Your co-authors must send a completedPublishing Agreement Formto半岛投注体育官网Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
More Online
Involvement of Type I Interferon Signaling in Muscle Stem Cell Proliferation During Dermatomyositis
Dr. Andrew Mammen and Dr. Payam Mohassel
► Watch
Topics Discussed
Alert Me
Recommended articles
- Views & Reviews
International Consensus Guidance for Management of Myasthenia Gravis2020 Update
Pushpa Narayanaswami, Donald B. Sanders, Gil Wolfe et al.
Neurology, November 03, 2020 - Brief Communications
Strong association of MuSK antibody–positive myasthenia gravis and HLA-DR14-DQ5E. H. Niks, J.B.M. Kuks, B. O. Roep et al.
Neurology, June 12, 2006 - Article
Clinical and therapeutic features of myasthenia gravis in adults based on age at onsetElena Cortés-Vicente, Rodrigo Álvarez-Velasco, Sonia Segovia et al.
Neurology, February 18, 2020 - Article
Subgroup stratification and outcome in recently diagnosed generalized myasthenia gravisMatthias Tomschik, Eva Hilger, Jakob Rath et al.
Neurology, July 08, 2020